Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHE/300314 stock hub

SHE/300314 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/300314is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.4B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/300314
In the news

Latest news · SHE/300314

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E39.2
P25 23.5P50 41.3P75 83.2
ROE7.3
P25 -0.9P50 4.1P75 8.8
ROIC10.5
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/300314 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
233
Groups with data
11
Currency
CNY
Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
920
Employees Change
4%
Employees Change Percent
0.44
Enterprise value
CNY 2.7B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Medical Devices
Isin
CNE100001DD1
Last refreshed
2026-05-10
Market cap
CNY 3.4B
Price
CNY 11.76
Price currency
CNY
Rev Per Employee
634,815.36x
Sector
Healthcare
Sic
3845
Symbol
she/300314
Website
https://www.nbdavid.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
2.57%
EV Earnings
31.28x
EV/EBIT
38.32x
EV/EBITDA
28.57x
EV/FCF
79.57x
EV/Sales
4.66x
FCF yield
1.01%
P/B ratio
2.75x
P/E ratio
39.2x
P/S ratio
5.8x
PE Ratio10 Y
63.75x
PE Ratio3 Y
44.33x
PE Ratio5 Y
44.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
12.17%
EBITDA Margin
15.83%
FCF margin
5.86%
Gross margin
53.25%
Gross Profit
CNY 311M
Gross Profit Growth
5.95%
Gross Profit Growth Q
38.12%
Gross Profit Growth3 Y
1.69%
Gross Profit Growth5 Y
2.88%
Net Income
CNY 87.1M
Net Income Growth
52.02%
Net Income Growth Years
1%
Net Income Growth3 Y
-3.66%
Net Income Growth5 Y
-8.56%
Pretax Margin
16.89%
Profit Margin
14.91%
Profit Per Employee
CNY 94,623
Profitable Years
18
ROA
3.06
Roa5y
3.97
ROCE
5.73
ROE
7.25
Roe5y
8.64
ROIC
10.46
Roic5y
19.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
-5.93%
Cagr1y
-2.62%
Cagr3y
-16.46%
Cagr5y
-5.75%
Div CAGR10
7.18%
Div CAGR3
-18.9%
Div CAGR5
-4.36%
EPS Growth
50
EPS Growth Years
1
EPS Growth3 Y
-4.09
EPS Growth5 Y
-8.59
FCF Growth Q
37.2%
FCF Growth3 Y
-17.88%
FCF Growth5 Y
-21.32%
OCF Growth
-4.92%
OCF Growth Q
-6.75%
OCF Growth10 Y
6.31%
OCF Growth3 Y
-7.17%
OCF Growth5 Y
-8.31%
Revenue Growth
10.82x
Revenue Growth Q
54.21x
Revenue Growth Years
1x
Revenue Growth3 Y
4.89x
Revenue Growth5 Y
4.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
CNY 0.4
Assets
CNY 1.5B
Cash
CNY 670M
Current Assets
CNY 934.7M
Current Liabilities
CNY 251.8M
Debt
CNY 6M
Debt EBITDA
CNY 0.06
Debt Equity
CNY 0
Debt FCF
CNY 0.18
Equity
CNY 1.2B
Interest Coverage
165.7
Liabilities
CNY 258.8M
Long Term Assets
CNY 557.1M
Long Term Liabilities
CNY 7M
Net Cash
CNY 664M
Net Cash By Market Cap
CNY 19.6
Net Cash Growth
-0.43%
Net Debt EBITDA
CNY -7.18
Net Debt Equity
CNY -0.54
Net Debt FCF
CNY -19.4
Tangible Book Value
CNY 1.2B
Tangible Book Value Per Share
CNY 4.12
WACC
4.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.71
Inventory Turnover
1.42
Net Working Capital
CNY 15.8M
Quick ratio
2.85
Working Capital
CNY 682.9M
Working Capital Turnover
CNY 0.86

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-1.35%
Dividend Growth
-8.05%
Dividend Growth Years
0%
Dividend per share
CNY 0.08
Dividend Years
15
Dividend Yield
0.68%
Ex Div Date
2026-05-12
Last Dividend
CNY 0.08
Payout Frequency
Annual
Payout Ratio
28.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-45.74%
1Y total return
-2.62%
200-day SMA
13.63
3Y total return
-41.7%
50-day SMA
12.98
50-day SMA vs 200-day SMA
50under200
5Y total return
-25.62%
All Time High
58.85
All Time High Change
-80.02%
All Time High Date
2015-06-18
All Time Low
6.13
All Time Low Change
91.91%
All Time Low Date
2012-12-04
ATR
0.34
Beta
0.06
Beta1y
0.52
Beta2y
0.54
Ch YTD
-6.52
High
11.78
High52
17.4
High52 Date
2025-08-12
High52ch
-32.41%
Low
11.6
Low52
11.17
Low52 Date
2026-04-24
Low52ch
5.28%
Ma50ch
-9.36%
Price vs 200-day SMA
-13.71%
RSI
39.2
RSI Monthly
45.08
RSI Weekly
36.71
Sharpe ratio
-0x
Sortino ratio
0.17
Total Return
-0.67%
Tr YTD
-6.52
Tr1m
-8.27%
Tr1w
1.47%
Tr3m
-18.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
CNY 71.1M
Operating Income Growth
17.67
Operating Income Growth3 Y
-5.98
Operating Income Growth5 Y
-6.41
Operating margin
12.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
95,655,264%
Net Borrowing
-3,442,474
Shares Insiders
66.79%
Shares Institutions
1.73%
Shares Out
288,000,000
Shares Qo Q
2.92%
Shares Yo Y
1.35%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
CNY 34.2M
Average Volume
4,035,482.65x
Bv Per Share
4.28
CAPEX
CNY -55M
Ch10y
-49.64
Ch1m
-8.27
Ch1w
1.47
Ch1y
-3.29
Ch3m
-18.11
Ch3y
-43.49
Ch5y
-28.68
Ch6m
-13.47
Change
1.38%
Change From Open
1.2
Close
11.6
Days Gap
0.17
Depreciation Amortization
21,412,004
Dollar Volume
34,762,560
Earnings Date
2026-08-20
EBIT
CNY 71.1M
EBITDA
CNY 92.5M
EPS
CNY 0.3
F Score
5
FCF
CNY 34.2M
FCF EV Yield
1.26x
FCF Per Share
CNY 0.12
Financing CF
-28,498,474
Fiscal Year End
December
Founded
1,992
Graham Number
5.37568
Graham Upside
-54.29
Income Tax
CNY 11.6M
Investing CF
50,470,717
Is Primary Listing
1
Last Earnings Date
2026-04-03
Last Report Date
2025-12-31
Last Split Date
2015-05-20
Last Split Type
Forward
Lynch Fair Value
CNY 1.5
Lynch Upside
-87.24
Ma150
13.42
Ma150ch
-12.37%
Ma20
12.25
Ma20ch
-4.03%
Net CF
106,351,510
Next Earnings Date
2026-08-20
Open
11.62
P FCF Ratio
98.97
P OCF Ratio
37.95
Payment Date
2026-05-12
Position In Range
88.89
Ppne
378,449,752
Price Date
2026-05-08
Price EBITDA
CNY 36.62
Ptbv Ratio
2.85
Relative Volume
0.75x
Revenue
584,030,132x
Tax By Revenue
1.99x
Tax Rate
11.76%
Tr6m
-13.47%
Volume
2,956,000
Z Score
10.42
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/300314 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.7%
$0.08 annual per share
Payout ratio
+28.8%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-4.4%
0 consecutive years of growth
Total shareholder yield
-0.7%
Next ex-dividend date: 2026-05-12
Performance

SHE/300314 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-2.6%
S&P 500 1Y: n/a
3Y total return
-41.7%
S&P 500 3Y: n/a
5Y total return
-25.6%
S&P 500 5Y: n/a
10Y total return
-45.7%
S&P 500 10Y: n/a
Ownership

Who owns SHE/300314?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.7%
Share of float held by funds and institutions
Insider ownership
+66.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.3%
Negative means the company is buying back shares.
Technical

SHE/300314 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
39.2
Neutral momentum band
Price vs 200-day MA
-13.7%
50/200-day relationship not available
Beta (5Y)
0.06
Less volatile than the market
Sharpe ratio
-0.00
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/300314

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300314 stock rating?

she/300314 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300314 analysis?

The full report lives at /stocks/she/300314/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300314?

The latest report frames she/300314 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300314 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

she/300314 stock profile: metrics, valuation and analysis | وكيل سوق الأسهم بالذكاء الاصطناعي